Home News & Events Press Releases
Press Releases
   Display # 
1 May 7, 2012 -Celladon Corporation Completes Second Close of Recent Venture Financing
2 Feb15, 2012 - Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure
3 Dec 12, 2011 - Celladon Corporation Receives FDA Fast Track Designation for its Investigational Agent MYDICAR® for the Treatment of Heart Failure
4 June 27, 2011 - Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results with MYDICAR® Enzyme Replacement Therapy in the Journal Circulation
5 May 23, 2011 - Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo
6 November 15, 2010 - Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo
7 May 30, 2010 - Phase 2 Clinical Trial Data Show Significant Improvements in Outcomes and Symptoms in Advanced Heart Failure Patients Treated with Celladon’s Genetically Targeted Enzyme Replacement Therapy MYDICAR®
8 April 28, 2010 - Celladon Corp. Announces that MYDICAR® Meets Primary Endpoint in Phase 2 Trial for Treatment of Advanced Heart Failure
9 March 23, 2010 - Celladon Corporation receives Notice of Allowance by U.S. Patent and Trademark Office for Broad Patent Covering Lead Drug Candidate MYDICAR®
10 November 23, 2009 - University of Minnesota, in Collaboration with Celladon Corporation, Invent Technology to Speed Development of Treatments in Heart Failure
 
<< Start < Prev 1 2 3 Next > End >>
Page 1 of 3

MYDICAR®

image
Enzyme Replacement Therapy to Treat Advanced Heart Failure. Learn more...

Clinical Trials

...The mean duration of hospitalization in the MYDICAR® high dose group during the 12-month period was 0.4 days per patient compared with 4.5 days per patient in the placebo group. This finding is especially noteworthy because heart failure is the leading cause of hospitalization in Americans 65 years of age and older... Read More